Taking action early to manage emergence of acquired resistance to osimertinib or other third generation EGFR inhibitors

Detalles Bibliográficos
Autores principales: Ma, Guangzhi, Sun, Shi-Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2021
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8443234/
https://www.ncbi.nlm.nih.gov/pubmed/34541036
http://dx.doi.org/10.18632/oncoscience.544
_version_ 1783753147018117120
author Ma, Guangzhi
Sun, Shi-Yong
author_facet Ma, Guangzhi
Sun, Shi-Yong
author_sort Ma, Guangzhi
collection PubMed
description
format Online
Article
Text
id pubmed-8443234
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-84432342021-09-16 Taking action early to manage emergence of acquired resistance to osimertinib or other third generation EGFR inhibitors Ma, Guangzhi Sun, Shi-Yong Oncoscience Editorial Impact Journals LLC 2021-09-15 /pmc/articles/PMC8443234/ /pubmed/34541036 http://dx.doi.org/10.18632/oncoscience.544 Text en https://creativecommons.org/licenses/by/3.0/Copyright: © 2021 Ma and Sun. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Editorial
Ma, Guangzhi
Sun, Shi-Yong
Taking action early to manage emergence of acquired resistance to osimertinib or other third generation EGFR inhibitors
title Taking action early to manage emergence of acquired resistance to osimertinib or other third generation EGFR inhibitors
title_full Taking action early to manage emergence of acquired resistance to osimertinib or other third generation EGFR inhibitors
title_fullStr Taking action early to manage emergence of acquired resistance to osimertinib or other third generation EGFR inhibitors
title_full_unstemmed Taking action early to manage emergence of acquired resistance to osimertinib or other third generation EGFR inhibitors
title_short Taking action early to manage emergence of acquired resistance to osimertinib or other third generation EGFR inhibitors
title_sort taking action early to manage emergence of acquired resistance to osimertinib or other third generation egfr inhibitors
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8443234/
https://www.ncbi.nlm.nih.gov/pubmed/34541036
http://dx.doi.org/10.18632/oncoscience.544
work_keys_str_mv AT maguangzhi takingactionearlytomanageemergenceofacquiredresistancetoosimertiniborotherthirdgenerationegfrinhibitors
AT sunshiyong takingactionearlytomanageemergenceofacquiredresistancetoosimertiniborotherthirdgenerationegfrinhibitors

Ejemplares similares